Drug Shortage Report for TEVA-ROSUVASTATIN

Last updated on 2020-10-15 History
Report ID 120318
Drug Identification Number 02354608
Brand name TEVA-ROSUVASTATIN
Common or Proper name ROSUVASTATIN 5MG TAB
Company Name TEVA CANADA LIMITED
Market Status MARKETED
Active Ingredient(s) ROSUVASTATIN
Strength(s) 5MG
Dosage form(s) TABLET
Route of administration ORAL ORAL
Packaging size p pack 30's
ATC code C10AA
ATC description LIPID MODIFYING AGENTS, PLAIN
Reason for shortage Shortage of an inactive ingredient or component.
Anticipated start date
Actual start date 2020-07-14
Estimated end date 2021-01-31
Actual end date
Shortage status Actual shortage
Updated date 2020-10-15
Company comments Allocating to 100% of Teva market until dec 2020
Health Canada comments
Contact Address 30 NOVOPHARM COURT
TORONTO, ONTARIO
CANADA M1B 2K9
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v7 2020-10-15 French Compare
v6 2020-10-15 English Compare
v5 2020-09-22 French Compare
v4 2020-09-22 English Compare
v3 2020-07-15 English Compare
v2 2020-07-14 French Compare
v1 2020-07-14 English Compare